Elhan Webb | executive |
Richard Paulson | executive |
Reshma Rangwala | executive |
Sohanya Cheng | executive |
Michael Mason | executive |
Kevin Strang | analyst |
Colleen Hanley | analyst |
Nicole Gabreski | analyst |
Matthew Cowper | analyst |
Good morning. My name is Jason, and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics Second Quarter 2023 Financial Results Conference Call. [Operator Instructions]. Please be advised that this call is being recorded at the company's request. I would now like to turn the call over to Elhan Webb, Senior Vice President of Investor Relations.